Executive Team
Paul Young | Chief Executive Officer & Head of Production
Professor Paul Young has more than 25 years experience in industry and academia, entrepreneurship, business creation and strategic development. Paul has held the Inaugural Chair of Commercialisation in the Faculty of Medicine and Health at the University of Sydney and was was the Deputy Executive Director of the Woolcock Institute of Medical Research, ranked no.1 Medical Research Institute globally in respiratory medicine. He has established a number of successful SMEs including Nanopharm Ltd, OzUK Ltd, Pulmatix Pty Ltd, and has worked on numerous products that have come to market with scientific specialty in the area of pharmaceutical product development.
Hui Xin Ong (YY) | Chief Scientific Officer & Head of R&D
Dr. Ong has pioneered methodological platforms to help accelerate the translation of new discoveries to clinical practice and has extensive experience working with diverse experts from academia and industry to develop numerous innovative pharmaceutical formulations. Dr. Ong is a leader in the field of aerosol pharmaceutical and medical device technologies used in the treatment of chronic respiratory and infectious diseases. She is a Lecturer in Pharmacology at the Faculty of Medicine and Health and a Research Leader within the Respiratory Technology Department at the Woolcock Institute of Medical Research. Dr. Ong has an outstanding publication record and has received multiple competitive grants to support her current research.
Will Glover | Chief Operating Officer & Head of Quality
Dr Will Glover has over 20 years experience in the area of pharmaceutical product design and manufacturing and a PhD in Pharmaceutics from the University of Sydney. In his previous roles, Will has worked in process development chemistry at 3M, Program Manager at Nanomaterials Technology in Singapore, Project and QC Manager at GlaxoSmithCline in Australia, and New Product Introduction Manager at Phebra in Sydney. Will oversees the day-to-day operations and Manufacturing plant in Glebe.
Daniela Traini | Non Executive Director & Scientific Co-Founder
Professor Daniela Traini has. more than 25 years experience in pharmaceutical sciences with a focus on aerosol medicine. She is a current NHMRC Investigator (2020-2024) and past ARC Future Fellow (2012-2016), holding appointments at Macquarie University and the Woolcock Institute. Since 2005 she has published 300 full peer reviewed manuscripts, 4 patents and has attracted more than $20 Millions in competitive funding. Daniela sits on the board of directors, managing strategic academic-industry partnerships.